CI Therapy + Sensory Training for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a treatment called Constraint-Induced Movement Therapy (CI Therapy) combined with sensory training for stroke survivors. The goal is to improve the use and quality of movement in the arm and hand most affected by the stroke, while also addressing sensory issues. Participants will undergo an intensive therapy program over 2-3 weeks to determine if adding sensory training enhances recovery without hindering motor skill progress. Ideal participants are those who had a stroke at least six months ago and have moderate to severe movement issues in their affected arm but can still perform basic movements like shoulder, elbow, or wrist motions. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance stroke recovery therapies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for stroke patients?
Research shows that Constraint-Induced Movement Therapy (CIMT), like the one used in this trial, is generally safe for stroke patients. Studies have found that combining CIMT with other rehabilitation methods improves movement with only minor side effects. Specifically, no major impacts on grip strength, sensation, pain, or overall quality of life occur after the therapy.
Another study found that CIMT helps improve hand function, indicating the therapy is effective and well-tolerated. Importantly, when CIMT was used in different ways, such as with other therapies, improvements occurred without major side effects. This suggests that adding sensory elements, as in this trial, should be safe. However, since the sensory part is new, its specific effects are still being studied.
Overall, past research considers CIMT safe. The addition of sensory training is being explored to see if it offers more benefits without adding new risks.12345Why are researchers excited about this trial?
Constraint-Induced Movement Therapy Plus Sensory Components (CI Therapy + Sensory Components) is unique because it combines physical rehabilitation with sensory training, which is not typical in standard stroke recovery methods. Standard treatments often focus solely on physical exercises or occupational therapy to regain movement. However, CI Therapy + Sensory Components adds sensory retraining, which helps patients not only move better but also feel and respond more accurately to touch and other stimuli. Researchers are excited because this comprehensive approach could enhance brain plasticity, leading to faster and more effective recovery after a stroke.
What evidence suggests that CI Therapy plus sensory components is effective for stroke recovery?
Research has shown that Constraint-Induced Movement Therapy (CI Therapy) can improve arm and hand function after a stroke. Studies have found that this therapy encourages patients to use their affected arm more in everyday activities, leading to better movement quality. For instance, one study discovered that patients who underwent CI Therapy had much better arm function than those who did not. In this trial, all participants will receive CI Therapy with added sensory components. While traditional CI Therapy mainly focuses on improving movement, adding sensory training aims to address issues with feeling and touch, which have not been studied as much. Early signs suggest that including sensory training might boost overall recovery for stroke patients.15678
Who Is on the Research Team?
David Morris, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults who've had a stroke at least 6 months ago and have mild-to-severe difficulty moving their arm but can still do some basic movements. They should be able to use the affected arm a little in daily life, as shown by specific test scores.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive CI therapy plus somatosensory training components for the more-affected upper extremity for 2-3 weeks, depending on the level of UE impairment severity.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments including the Motor Activity Log and other measures.
What Are the Treatments Tested in This Trial?
Interventions
- Constraint-Induced Movement Therapy Plus Sensory Components
Constraint-Induced Movement Therapy Plus Sensory Components is already approved in United States, European Union for the following indications:
- Stroke rehabilitation
- Upper extremity motor impairment
- Hemiparesis
- Stroke rehabilitation
- Upper extremity motor impairment
- Hemiparesis
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor